Neuroprotective effect of the active components of three Chinese herbs on brain iron load in a mouse model of Alzheimer’s disease
Authors:
Open Access
- 29 January 2015
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 9 (4) , 1319-1327
Abstract
Alzheimer's disease (AD) is a neurodegenerative brain disorder and the most common cause of dementia. New treatments for AD are required due to its increasing prevalence in aging populations. The present study evaluated the effects of the active components of Epimedium, Astragalus and Radix Puerariae on learning and memory impairment, β‑amyloid (Aβ) reduction and brain iron load in an APPswe/PS1ΔE9 transgenic mouse model of AD. Increasing evidence indicates that a disturbance of normal iron homeostasis may contribute to the pathology of AD. However, the underlying mechanisms resulting in abnormal iron load in the AD brain remain unclear. It has been hypothesized that the brain iron load is influenced by the deregulation of certain proteins associated with brain iron metabolism, including divalent metal transporter 1 (DMT1) and ferroportin 1 (FPN1). The present study investigated the effects of the active components of Epimedium, Astragalus and Radix Puerariae on the expression levels of DMT1 and FPN1. The treatment with the active components reduced cognitive deficits, inhibited Aβ plaque accumulation, reversed Aβ burden and reduced the brain iron load in AD model mice. A significant increase was observed in the levels of DMT1‑iron‑responsive element (IRE) and DMT1‑nonIRE in the hippocampus of the AD mouse brain, which was reduced by treatment with the active components. In addition, the levels of FPN1 were significantly reduced in the hippocampus of the AD mouse brain compared with those of control mice, and these levels were increased following treatment with the active components. Thus, the present study indicated that the active components of Epimedium, Astragalus and Radix Puerariae may exert a neuroprotective effect against AD by reducing iron overload in the AD brain and may provide a novel approach for the development of drugs for the treatment of AD.Keywords
This publication has 57 references indexed in Scilit:
- Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's diseaseJournal of Trace Elements in Medicine and Biology, 2015
- Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's diseaseNeurobiology of Disease, 2006
- Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporterNeuroToxicology, 2006
- Pathophysiology of Alzheimer's DiseaseNeuroimaging Clinics Of North America, 2005
- The iron exporter ferroportin/Slc40a1 is essential for iron homeostasisCell Metabolism, 2005
- A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron MetabolismJournal of Biological Chemistry, 2000
- Transferrin Receptor 2-α Supports Cell Growth Both in Iron-chelated Cultured Cells and in VivoJournal of Biological Chemistry, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- The Human Nramp2 Gene: Characterization of the Gene Structure, Alternative Splicing, Promoter Region and PolymorphismsBlood Cells, Molecules, and Diseases, 1998
- Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter geneNature Genetics, 1997